FeesSafety
Pluang+

Plasma unlocks 1.81B XPL tokens for team and investors on Sept 25, 2026, marking a major supply increase.

Protocol Fundamentals
01 Sep 2026, 15:31 WIB
CryptoTicker
View Source
Neutral
Plasma unlocks 1.81B XPL tokens for team and investors on Sept 25, 2026, marking a major supply increase.

On September 25, 2026, Plasma will unlock 1.81 billion XPL tokens held by the team and investors after a one-year lock-up since the mainnet beta launch. This release represents about 65% of the circulating supply at that time and is part of a vesting schedule that will continue monthly until September 2028. The unlock increases the circulating supply from around 2.78 billion to about 4.67 billion XPL tokens, impacting market dynamics but not necessarily causing immediate selling pressure. The event is significant for investors tracking supply changes and tokenomics but does not guarantee price movement as unlocked tokens are not automatically sold.

More News

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
Bullish
1 hour ago
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
Bullish
1 hour ago
Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...

Others
Neutral
1 hour ago
New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...

Market News
Bullish
1 hour ago
AI data center stocks plunge amid capital crunch and political hurdles in Texas and New York.

AI data center stocks plunge amid capital crunch and political hurdles in Texas and New York.

Despite strong AI demand and record growth from cloud providers like AWS, AI data center stocks, especially former Bitcoin miners turned AI hosts, have fallen sharply due to tightening capital markets and political restrictions. Companies like Cipher...

Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App